Immune checkpoint inhibition and targeted therapy for melanoma: A patient-oriented cross-sectional comparative multicentre study.

Alexander ThiemPegah MashhadiakbarChristiane CussighJessica C HasselImke GrimmelmannRalf GutzmerMax SchlaakMarkus Vincent HepptPia DückerSvea HüningLena SchulmeyerBastian SchillingSebastian HaferkampMirjana ZiemerRose K C MoritzVictoria HagelsteinPatrick TerheydenChristian PoschMaria R GaiserPeter KroppSteffen EmmertBritta MüllerJulia K Tietze

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)

Patients evaluated their treatment mainly positively. ICI might be preferred over TT regarding QOL and patient-reported AEs in the adjuvant setting. Older melanoma patients appeared to be less impacted by their disease and more satisfied with their treatment.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
early stage
case report